BPC-157 10mg — Vial Spec, Reconstitution Math & COA

Overview and Purpose of the BPC-157 10mg Vial Specification

The 10mg format of Body Protection Compound-157 (BPC-157) is a bulk-oriented laboratory packaging unit designed for research teams conducting repeated dosing protocols in animal models or high-throughput cell culture assays. Containing 10 milligrams of solid lyophilized peptide cake, this specification minimizes vial-to-vial reconstitution variability across high-volume experimental runs. Researchers seeking standard catalog sizes or smaller single-protocol quantities can review the complete research peptide catalog or inspect the primary BPC-157 product page for available lot sizes.

Each 10mg vial is vacuum-sealed under an inert nitrogen atmosphere to prevent oxidative degradation during transport and storage. The synthetic peptide appears as a compact white to off-white cake. Because larger mass units like 10mg present distinct volumetric concentration dynamics upon liquid addition, accurate volumetric calculation is critical to achieving precise nanomolar or micromolar concentration targets in test media.

Molecular Structure and Mechanism of Action in Preclinical Models

BPC-157 is a 15-amino acid synthetic peptide (sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a protective protein fragment found in human gastric juice. In preclinical literature, this sequence demonstrates high stability in acid-base environments and strong resistance to enzymatic cleavage compared to endogenous growth factors.

In vitro studies and rodent tissue models indicate that BPC-157 acts primarily as a modulator of tissue repair cascades. Research demonstrates that the peptide upregulates Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) expression, initiating downstream signaling pathways that promote endothelial cell migration, sprouting angiogenesis, and capillary tube formation. Furthermore, preclinical models evaluating musculoskeletal repair demonstrate that BPC-157 stimulates focal adhesion kinase (FAK) and paxillin phosphorylation, driving fibroblast proliferation, tenocyte migration, and collagen type I synthesis at tissue disruption sites. Additional cellular investigations suggest local modulation of nitric oxide (NO) synthase pathways, contributing to cytoprotection across gastrointestinal mucosal barriers.

Laboratory Reconstitution Math for 10mg Mass

Reconstituting a 10mg (10,000 microgram) lyophilized vial requires accurate diluent measuring to establish predictable target concentrations. Researchers standardly utilize Bacteriostatic Water (0.9% benzyl alcohol) for multi-use analytical assays or Sterile Normal Saline (0.9% NaCl) for immediate cell culture applications. Utilizing our online peptide reconstitution calculator assists in verifying volumetric ratios prior to liquid transfer.

Below are the primary concentration breakdowns based on total added diluent volume to a 10mg active peptide mass:

1. Reconstitution with 1.0 mL Diluent: Total Volume = 1.0 mL (1,000 µL) Concentration = 10.0 mg/mL (10.0 µg/µL) A 50 µL volumetric aliquot delivers 500 µg of active peptide.

2. Reconstitution with 2.0 mL Diluent: Total Volume = 2.0 mL (2,000 µL) Concentration = 5.0 mg/mL (5.0 µg/µL) A 50 µL volumetric aliquot delivers 250 µg of active peptide.

3. Reconstitution with 3.0 mL Diluent: Total Volume = 3.0 mL (3,000 µL) Concentration = 3.33 mg/mL (3.33 µg/µL) A 50 µL volumetric aliquot delivers 166.7 µg of active peptide.

When transferring diluent into the vial, direct the stream gently along the glass wall rather than directly onto the lyophilized cake. Allow the cake to dissolve naturally or rotate the vial with gentle swirling. Rapid agitation or vigorous shaking must be avoided to prevent mechanical shearing of the peptide chain.

Aliquot Planning and Liquid-Phase Storage Protocols

While lyophilized peptide cakes maintain high chemical stability at reduced temperatures, reconstituted peptide solutions are susceptible to hydrolysis and aggregation over time. For protocols extending beyond 72 hours, laboratory best practices dictate subdividing the primary reconstituted stock into single-use micro-aliquots using sterile polypropylene low-binding tubes.

Reconstituted BPC-157 dissolved in Bacteriostatic Water maintains structural integrity for up to 28 days when preserved at 2°C to 8°C. If aliquots must be preserved for longer experimental windows, store them at -20°C or -80°C. Repeated freeze-thaw cycles must be rigorously avoided, as phase transitions induce structural stress on the peptide backbone, leading to precipitation or partial degradation.

Analytical Quality Control & Lot-Matched COA Verification

PX1 Research enforces strict analytical standards across every production run. Every batch of BPC-157 undergoes dual-stage verification using High-Performance Liquid Chromatography (HPLC) to establish chemical purity and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm molecular identity against theoretical mass (1419.56 Da).

Laboratory researchers can review independent analytical data via our PX1 COA database. Every lot-matched Certificate of Analysis documents purity metrics exceeding 99.0%, alongside bacterial endotoxin testing performed via Limulus Amebocyte Lysate (LAL) assay. PX1 Research guarantees endotoxin thresholds below 0.05 EU/mg, ensuring that peptide preparations do not introduce confounding inflammatory variables into sensitive cellular or in vivo research protocols.

Format Selection: Comparing 5mg vs. 10mg Vials for Research Protocols

Selecting between a 5mg and a 10mg vial depends entirely on the scale and duration of the planned experimental protocol. For short-term assays, lower total volume requirements, or preliminary pilot studies, a smaller 5mg format is often preferred to minimize reconstituted solution storage duration and avoid unused liquid turnover.

Conversely, high-density rodent studies, long-term cellular migration models, or multi-investigator research facilities benefit from the 10mg configuration. A larger fill size offers higher volumetric throughput from a single analytical lot, reducing baseline variable shift across multiple micro-plate preparations. Facilities requiring consistent multi-gram or bulk-vial supply for recurring study blocks can request dedicated institutional access through our wholesale lab accounts portal.

Comparative Analysis of Class-Related Tissue Repair Compounds

In preclinical tissue regeneration and cellular signaling research, BPC-157 is frequently evaluated alongside or in contrast to other bio-active peptide sequences targeting repair pathways. Understanding structural and mechanistic differences assists investigators in designing controlled comparative assays.

While BPC-157 targets VEGFR2 modulation and focal adhesion kinase pathways, TB-500 (a synthetic fragment of Thymosin Beta-4) operates by sequestering G-actin monomers, facilitating cell motility and tissue remodeling through cytoskeletal reorganization. Additionally, GHK-Cu functions via copper ion chelation to regulate gene expression related to extracellular matrix turnover and remodeling. For mucosal or immune-mediated signaling models, researchers also analyze KPV, an alpha-MSH tripeptide fragment evaluated for its anti-inflammatory signal modulation. Comparing these distinct pathways provides a comprehensive framework for mapping tissue repair mechanisms in vitro.

Lyophilized Stability and Facility Quality Standards

Unreconstituted BPC-157 10mg vials should be stored in a dry, dark environment at -20°C for long-term storage (up to 24 months) or 2°C to 8°C for short-term handling (up to 90 days). Exposure to heat, direct UV light, and ambient moisture must be strictly controlled to prevent thermal degradation or premature hydration of the cake.

All PX1 Research compounds are synthesized in state-of-the-art cGMP-compliant facilities located in the USA. Analytical verification is conducted by ISO 17025 accredited testing laboratories. Orders ship directly from our California and Arizona logistics hubs with same-day processing for orders placed Monday through Friday, ensuring rapid fulfillment for active research projects. Comprehensive methodology updates and technical whitepapers are accessible via our preclinical research hub.